Assertio (ASRT) came out with a quarterly loss of $1.86 per share versus the Zacks Consensus Estimate of a loss of $3.05. This compares to a loss of $1.65 per share a year ago. These figures are ...

Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.

$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

Below is Validea's guru fundamental report for ASSERTIO HOLDINGS INC (ASRT). Of the 22 guru strategies we follow, ASRT rates highest using our Acquirer's Multiple Investor model based on the published ...

In Q1 FY2023, Assertio achieved significant progress in executing the new strategy brought on board by CEO Dan Peisert. The market expects ASRT's EPS to decline nearly 82% YoY in FY2023, but then ...

Insider selling in Assertio raises red flags and erodes trust in management's statements. The magnitude and frequency of insider sales cast doubt on the company's trajectory and prompt a cautious ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Assertio (ASRT) is a stock that can certainly grab the attention ...

The world’s foremost artificial intelligence stock trading algorithm, An-E, predicts that Assertio (NASDAQ:ASRT) stock will gain 3% by June 1. An-E (pronounced Annie) has made this kind of prediction ...